Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations 2 years ago
Pierre Fabre, the parent company of Avène & Klorane in Ireland, launches the Green Impact Index 4 years ago
